News|Articles|September 2, 2004
- Pharmaceutical Technology-09-02-2004
- Volume 28
- Issue 9
Promoting Quality in Drug Manufacturing
Author(s)Jill Wechsler
FDA is re-engineering the CMC review process for innovator and generic drugs and backing risk-based ICH quality standards.
Advertisement
Articles in this issue
over 21 years ago
In the Spotlight-September 2004over 21 years ago
Automation in a Digital, Webbed, and Wireless Ageover 21 years ago
September 2004over 21 years ago
Design of an Aseptic Process Simulationover 21 years ago
Early Development Still Driving CRO Performanceover 21 years ago
Particulate-Free PalletsNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
EMA Calls New EU Pharma Legislation Most Significant in Two Decades
2
European Parliament Revamps Pharmaceutical Policy Framework
3
Tjoapack’s Advanced Packaging Expansion Aims to Meet Rising Demand
4
FDA’s CNPV Pilot Gives First Approval to Antibiotic for Pneumonia and Sinusitis
5
